Neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates from 17 persons who were long-term disease nonprogressors (LTNPs) and 13 persons who were fast progressors (FPs) was compared. Sera from LTNPs showed higher neutralizing activity both in titer and in host spectrum than did sera from FPs. However, LTNP sera had limited neutralizing activity against HIV-1 subtypes from different geographic areas. Sera collected 6 years earlier from both groups had limited neutralizing activity, indicating that early responses are not predictive for disease progression. LTNPs had very low virus loads, as reflected by only one positive isolation, which was an MT-2 -negative phenotype. Virus was isolated from all FPs, and the isolates showed a phenotype switch from MT-2 negative to MT-2 positive. Development of high-titer, broadly cross-reactive neutralizing antibodies is associated with control of virus replication and low virus load in HIV-1 -infected LTNPs.
Human immunodeficiency virus type 1 (HIV-1) infection is
primary isolates has more frequently been demonstrated in LTNP sera than in sera from persons with rapidly progressing characterized in humans by a gradual, persistent loss of CD4 / T lymphocytes, continuous virus replication, and progression disease (fast progressors [FPs] ) [9, 10, 15] . However, by testing neutralizing activity against laboratory strains MN, RF, and to AIDS within an average of 8 -10 years [1 -3] . However, a small number of infected persons, termed long-term nonpro-HXB2, Hogervorst et al. [7] found an increase in neutralizing titers during the course of infection in both groups. In another gressors (LTNPs) or long-term slow progressors, show a benign course of infection in that they have stable CD4 cell counts, study [17] using autologous viruses, high neutralizing activity correlated with a slow rate of CD4 / T cell decline and stable low virus load, and are free of AIDS for many years [3 -10] .
Both viral and host factors, genetic and immunologic factors, clinical stage during a 2-year follow-up. The limited number of longitudinal studies leaves the question open as to the role have been implied in this slowing down of the pathogenic process. In some cases, it has been suggested that infection of neutralizing antibodies in modulating the disease progression rate in HIV-1 -infected persons. occurred by attenuated HIV-1 strains [8, 11] , while in other cases, an HIV-1 quasispecies defective in env and multiple
In this study, the neutralizing activity of sera from LTNPs and FPs was compared with a panel of 8 primary HIV-1 isolates accessory genes was identified and used to explain the limited success of virus isolation from LTNPs [7, 10, 12 -15] . The few to determine if the level and cross-reactivity of neutralizing antibodies over time was associated with control of virus repli-HIV-1 isolates obtained from LTNPs had a low cytopathogenic, nonsyncytium-inducing phenotype [7, 10, 15] . In addition, host cation and virus load. Serum samples collected 6 years earlier were also available from a selected group of patients. immunity may contribute to limiting the virus load [9, 10, 13, 16] . In this respect, CD8
/ cytotoxic T cells and neutralizing antibodies have been considered [9, 10, 16] . In cross-sectional Materials and Methods studies, neutralizing activity against T cell line -adapted and Study subjects. The study population consisted of 17 HIV-1-infected persons from the Italian Cohort of Hemophiliac Patients (10 LTNPs and 7 FPs) and 13 HIV-1-infected intravenous drug Hemophiliacs  18  1985  502  5  AsymptrAIDS  ND  ND  19  1990  670  37  AsymptrAIDS  ND  ND  20  1985  482  105  AsymptrAIDS  ND  ND  21  1982  482  69  AsymptrAIDS  ND  ND  22  1983  452  162  AsymptrAIDS  ND  ND  23  1984  481  122  AsymptrAIDS  ND  ND  24  1982  746  56  AsymptrAIDS  ND  ND  IVDUs  25  1990‡   777  74  AsymptrAIDS  NSI  SI  26  1990‡   455  42  AsymptrAIDS  NSI  NSI  27  1989‡   515  10  AsymptrAIDS  NSI  SI  28  1988‡   754  16  AsymptrAIDS  NSI  SI  29  1988‡   778  2  AsymptrAIDS  NSI  SI  30 [20] . MT-2 cells were infected with cell-free supernatants or cocultivated with infected donor PBMC and evaluated for virus replication (HIV-1 p24 antigen ELISA) and for syncytium formation as
Results
previously described [20, 21] .
CD4
/ T lymphocyte counts. All LTNPs were asymptom- (southeastern Italy) were used for preparing virus stocks [18] .
Based on two CD4 cell counts 6 years apart, CD4 cell numbers CD4 cell values in the 2 groups showed highly significant dium supplemented with 10% fetal calf serum, 10 U of interleukindifferences (P õ .001). Comparing the smaller groups from 2/mL (Amersham, Little Chalfont, UK), and 2 mg/mL polybrene.
which the samples from two time points were available showed Culture supernatants were collected 7-10 days after infection when p24-antigen content was ú2 ng/mL, centrifuged, aliquoted, no difference in CD4 / lymphocyte counts at first sampling and frozen at 070ЊC.
(P Å .1) and a significant difference between the groups at ID 50 titration and neutralization assay. Virus ID 50 titrations second sampling (P Å .01, Student's t test).
and neutralization assays were done as described [23] . For ID 50
Virus isolation and characterization. Virus isolations were titration, 75-mL aliquots of virus supernatants were diluted in meattempted and were successful from both early and late PBMC dium with 5-fold, eight-step dilutions in 96-well round-bottom samples of 6 FPs by using the standard isolation technique. plates (Costar, Cambridge, MA). Thereafter, another 75 mL of From all 6 early samples and from 1 late sample, MT-2 -medium was added to each well, and the mixture was incubated negative nonsyncytium-inducing viruses were recovered, while at 37ЊC for 1 h. Subsequently, 10 5 phytohemagglutinin-activated the remaining 5 isolates obtained from the late samples were PBMC from 2 donors was added to each well. The plates were able to replicate and induce syncytia in MT-2 cells, in agreewashed at days 1 and 3 by centrifugation and medium change. At ment with previous findings on the relationship between proday 7, 100 mL of culture supernatant was analyzed in an in-house HIV-1 p24 antigen-capture ELISA [24] . The ID 50 was defined as gressive disease and HIV-1 biologic phenotype [20, 25] . In the reciprocal of the virus dilutions resulting in 50% of the positive contrast, only 1 sample from the LTNP group yielded virus at wells for virus p24 antigen production (Reed-Muench calculation). the second sampling. This isolate was MT-2 negative. The For the neutralization assay, sera were inactivated at 56ЊC for results suggest that virus load was lower in LTNPs than in 30 min and then diluted in medium (ten 2-fold dilution steps startFPs. ing from 1:10 sera neutralized only 3 viruses. The frequent neutralization of areas. The high-titer neutralizing activity in LTNP sera prompted us to further test the cross-neutralizing capacity of viruses from the same geographic area indicates that broadly cross-reactive neutralizing activity was present in the serum these sera. HIV-1 of genetic subtypes A and D were from Uganda, and 1 subtype E was from the Central African Repubof LTNPs. It is interesting to note that, when compared, the neutralizing activity of the LTNP and FP sera for each virus lic. Viruses were tested for neutralization with 7 selected sera from the LTNP group. As shown in table 3, all sera neutralized yielded statistically significant differences for only 3 of 6 viruses. This indicates that the choice of test virus influences the 2 subtype A viruses (UG92031 and UG92037), but only 2 sera neutralized the subtype D virus (UG92046). One serum the results of neutralization, a feature that has been observed previously [26] .
neutralized subtype E virus (CAR4039), against which even our positive control serum (SE1785 from a patient presumably that high-titer neutralizing activity against HIV-1 primary isolates from the same geographic area is frequently present in the serum of LTNPs. This is in contrast with the FP control group and with previously published results in progressive ity. Taken together, the results show that even if high-titer neutralizing activity by LTNP sera can be demonstrated against HIV-1 infection, in which neutralizing activity is often lacking or, if present, has a low titer [17, 29] . a panel of primary isolates from the same geographic area, the capacity to cross-neutralize is not particularly prominent and
Serum-neutralizing activity against primary HIV-1 isolates of subtypes A, D, and E obtained from different geographic
Our results are in agreement with those of Cao et al. [10] , who found that LTNPs produced a broad neutralizing antibody in only 2 cases is as high as with serum SE1785, the positive control serum. (table 4) . Strikingly, early sera from patients 1.3% of FPs. Even though technical differences in the neutralization assay might account for some of these different results who were later diagnosed as LTNPs had neutralizing activity less frequently than did early sera from FPs (15/48 [31% posi-[30] , the most important factor to consider is the selection of the LTNP groups. It is not simple to define long-term nonprotive neutralization reactions] vs. 30/48 [62%]). When the 2 groups were compared separately for each virus, there was a gression, and cohorts studied by different investigators may differ in important features [15, 31, 32] . However, in our study, statistically significant difference with only 1 virus, even if comparison of the 2 groups as a whole showed a difference. the pattern of virus neutralization was similar in hemophiliacs and IVDUs. In both groups, differences in serum-neutralizing As detailed above (table 2), sampling 6 years later showed an inverse relationship between the 2 groups with regard to activity were encountered according to the severity of HIV-1 infection. Similarly, it did not make any difference whether their capacity to neutralize primary isolates (i.e., positive neutralization reactions were more frequent in LTNPs [85%] than viruses from hemophiliacs or IVDUs were used in the neutralization assay. Therefore, the infection risk category does not in FPs [41%] ). The median neutralizing titer in late serum samples for LTNPs was 1:80 (25th -75th percentile, 1:40 -seem to influence the outcome of neutralization, and there is no bias in the selection of IVDUs for the retrospective study. 1:320), and for FPs it was 1:20 (25th -75th percentile, 1:20 -1:20). However, when neutralizing titers with early serum samFurthermore, 2 LTNPs (patient nos. 14 and 15) showed infrequent and low-titer neutralization similar to that for 3 FPs ples were compared, the median titer for LTNPs was the same as that for FPs (1:20; 25th -75th percentile, 1:20 -1:40) but (patient nos. 21, 23, and 24), demonstrating that our LTNP groups were heterogeneous. lower compared with titers 6 years later (1:80; 25th -75th percentile, 1:40 -1:320) ( figure 1 ). This indicates that neutralizing
We used the serum samples collected 6 years earlier to further compare the neutralizing activity between 6 LTNPs and activity, both by frequency and titer, increased over time in the LTNP group but decreased in the FP group. This selected 6 FPs. Since patients in both groups had similar CD4 / T cell / 9d39$$no24 09-11-97 14:15:36 jinfa UC: J Infect counts and were all asymptomatic at the time of first sampling, response in LTNPs might be related to the extremely low virus load and the low amount of antigen available for immune they provided an ideal situation for comparison. At this early time, sera in both groups had infrequent, low-titer neutralizing stimulation. The failure to isolate HIV-1 from these persons lends further support to this notion. This is reminiscent of activity (table 4) . Of interest, the number of positive neutralization reactions was lower in LTNPs (31%) than FPs (62%)
HIV type 2 -infected macaques, with whom there was a strict correlation between success of virus isolation and appearance (P Å .002). We propose that such an infrequent neutralizing of neutralizing activity in serum [33, 34] . This may indicate that a potent neutralizing antibody response is dependent on proper viral antigenic stimulation, and if antigen levels are below a threshold due to slow replicative capacity of the virus or cell-to-cell spread, no or less neutralizing antibody response will be evoked. With respect to virus load, our LTNPs seemed to have a low level not only at first sampling but also 6 years later. Of repeated isolation attempts at second sampling only one yielded virus. This was the case even when CD8 / T lymphocytes were removed prior to the initiation of isolation cultures. This indicates that, indeed, virus load must have been low in these persons and the failure to isolate virus was not merely due to suppression of virus replication by CD8 / cells [9, 15] . Attenuated HIV-1 with defective env and multiple defective accessory genes were documented and were suggested to be the cause of long-term nonprogression [12 -14, 27] . Patients with such [35, 36] .
Next to titer, the specificity of neutralizing activity, broad or activity over time and control of virus replication, FPs are unable to do so. Lack of control of virus replication may lead narrow, is of interest. We found previously that broadly crossreactive neutralizing activity in serum was associated with lack to continuous damage of the immune system and increasing severity of HIV-1 infection. of disease development in HIV-2-infected macaques [34] . Also in SIV infection, long-term survivors mounted neutralizing activity with broader specificity than that of macaques that died early Acknowledgments from immunodeficiency [37] . Among HIV-1-infected mothers who did not transmit HIV-1 to their children, there was a signifi- In view of these findings, it was particularly interesting to test the specificity of neutralization in the LTNP group. We found a broadly cross-neutralizing activity against isolates from individuals with exceptionally broad neutralizing activity, like our Swedish control SE1785, in general, neutralizing capacity is also restricted in LTNPs. The results are in line with those
